Bezisterim produces moderate and broad treatment effects in several different long COVID subsets. BioVie, the drug manufacturer, hopes to move forward with a big phase III trial.
Geoff’s Narration The GIST Personal Update A Big Crash – I always feel compelled to explain what happened when the blogs suddenly stop for an extended time. This time it was a self-inflicted injury – which is a good thing, really. I am usually...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.